HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bo Zheng Selected Research

galactosyl- beta(1- 3)- N- acetylglucosaminyl- beta(1- 3)galactose

1/2020Bypassing Phase Variation of Lipooligosaccharide (LOS): Using Heptose 1 Glycan Mutants To Establish Widespread Efficacy of Gonococcal Anti-LOS Monoclonal Antibody 2C7.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Bo Zheng Research Topics

Disease

47Neoplasms (Cancer)
04/2022 - 04/2013
23Infections
07/2022 - 12/2002
12Inflammation (Inflammations)
01/2022 - 11/2012
10COVID-19
11/2022 - 06/2020
9Stroke (Strokes)
01/2022 - 01/2013
8Hepatocellular Carcinoma (Hepatoma)
12/2021 - 05/2017
7Adenocarcinoma of Lung
04/2022 - 09/2015
7Carcinogenesis
03/2022 - 04/2013
7Gonorrhea
01/2022 - 01/2013
7Myocardial Infarction
11/2021 - 08/2012
5Neoplasm Metastasis (Metastasis)
03/2022 - 01/2017
5Thrombosis (Thrombus)
11/2021 - 11/2009
5Body Weight (Weight, Body)
01/2021 - 05/2016
4Ulcerative Colitis
08/2022 - 05/2011
4Alzheimer Disease (Alzheimer's Disease)
11/2021 - 01/2017
4Urinary Tract Infections (Urinary Tract Infection)
08/2021 - 12/2002
4Hyperplasia
01/2021 - 11/2009
4Wounds and Injuries (Trauma)
08/2020 - 01/2017
4Hyperthermia
01/2020 - 01/2017
4Chronic Renal Insufficiency
09/2019 - 08/2012
3Acute Coronary Syndrome
07/2022 - 10/2015
3Stomach Neoplasms (Stomach Cancer)
04/2022 - 01/2018
3Respiratory Tract Infections (Respiratory Tract Infection)
01/2022 - 12/2002
3Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 01/2021
3Coronary Disease (Coronary Heart Disease)
01/2022 - 01/2021
3ST Elevation Myocardial Infarction
01/2022 - 08/2012
3Hemorrhage
01/2022 - 12/2017
3Small Cell Lung Carcinoma (Small Cell Lung Cancer)
12/2021 - 01/2021
3Parkinson Disease (Parkinson's Disease)
12/2021 - 01/2013
3Diabetes Mellitus
11/2021 - 08/2012
3Breast Neoplasms (Breast Cancer)
11/2021 - 01/2020
3Lung Neoplasms (Lung Cancer)
01/2021 - 01/2015
3Carcinoma (Carcinomatosis)
01/2021 - 07/2016
3Atrial Fibrillation
01/2021 - 12/2015
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2020 - 12/2018
3Liver Neoplasms (Liver Cancer)
06/2019 - 05/2017
3Systemic Lupus Erythematosus (Libman-Sacks Disease)
05/2016 - 09/2007
3Schizophrenia (Dementia Praecox)
01/2015 - 06/2013
2Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
08/2022 - 01/2012
2Osteosarcoma (Osteogenic Sarcoma)
03/2022 - 02/2014
2Pathologic Constriction (Stenosis)
02/2022 - 01/2017
2Hyperhomocysteinemia
12/2021 - 01/2012
2Rheumatoid Arthritis
05/2021 - 01/2011
2Hypertension (High Blood Pressure)
01/2021 - 01/2013
2Cholangiocarcinoma
01/2021 - 11/2017
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021 - 12/2017
2Esophageal Squamous Cell Carcinoma
08/2020 - 01/2020
2Adenocarcinoma
09/2019 - 12/2018
2Renal Insufficiency (Renal Failure)
09/2019 - 08/2012
2Starvation
01/2019 - 01/2018
2Burns
01/2019 - 09/2017
2Male Infertility (Male Sterility)
01/2019 - 12/2013

Drug/Important Bio-Agent (IBA)

13Proteins (Proteins, Gene)FDA Link
01/2022 - 04/2013
12Biomarkers (Surrogate Marker)IBA
08/2022 - 01/2017
9Pharmaceutical PreparationsIBA
07/2022 - 11/2009
8MicroRNAs (MicroRNA)IBA
08/2022 - 11/2017
8Anti-Bacterial Agents (Antibiotics)IBA
01/2022 - 01/2013
7Long Noncoding RNAIBA
06/2022 - 11/2017
7VaccinesIBA
01/2022 - 01/2013
6PolymersIBA
11/2021 - 11/2009
5DNA (Deoxyribonucleic Acid)IBA
08/2022 - 10/2013
5Glucose (Dextrose)FDA LinkGeneric
10/2020 - 01/2013
4LigandsIBA
11/2022 - 09/2016
4Sirolimus (Rapamycin)FDA Link
11/2021 - 11/2009
4Immune Checkpoint InhibitorsIBA
01/2021 - 12/2020
4Monoclonal AntibodiesIBA
01/2021 - 10/2010
4AntibodiesIBA
11/2019 - 01/2013
3RNA (Ribonucleic Acid)IBA
06/2022 - 06/2017
3AntigensIBA
04/2022 - 01/2011
3Messenger RNA (mRNA)IBA
03/2022 - 03/2016
3CytokinesIBA
01/2022 - 06/2017
36-methyladenineIBA
11/2021 - 01/2021
3Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
06/2021 - 01/2018
3Immunoglobulin G (IgG)IBA
01/2021 - 01/2012
3LipidsIBA
10/2020 - 09/2015
3Peptides (Polypeptides)IBA
08/2020 - 10/2010
3Sorafenib (BAY 43-9006)FDA Link
01/2020 - 05/2017
3Biological ProductsIBA
03/2019 - 11/2017
3FosfomycinFDA Link
01/2015 - 12/2013
2SilverIBA
08/2022 - 05/2021
2ChemokinesIBA
01/2022 - 12/2021
2Transcription Factors (Transcription Factor)IBA
12/2021 - 09/2016
2Phenobarbital (Luminal)FDA Link
11/2021 - 01/2017
2Air Pollutants (Pollutants, Air)IBA
04/2021 - 12/2018
2Environmental Pollutants (Pollutants, Environmental)IBA
02/2021 - 12/2018
2Antihypertensive Agents (Antihypertensives)IBA
01/2021 - 06/2015
2Cell-Free Nucleic AcidsIBA
01/2021 - 01/2021
2LipopolysaccharidesIBA
01/2021 - 08/2020
2CholesterolIBA
01/2021 - 09/2019
2Carbon DioxideIBA
11/2020 - 10/2020
2EpitopesIBA
11/2019 - 01/2013
2MetalsIBA
01/2019 - 01/2017

Therapy/Procedure

34Therapeutics
12/2022 - 02/2007
9Immunotherapy
01/2022 - 04/2013
7Percutaneous Coronary Intervention
07/2022 - 08/2012
7Stents
01/2022 - 11/2009
3Precision Medicine
01/2020 - 01/2017
3Injections
09/2017 - 06/2014
2Secondary Prevention
01/2022 - 05/2017
2Neoadjuvant Therapy
08/2020 - 01/2020